News roundup [abridged versions appear in the paper journal]

Vaccine protects against Ebola virus

BMJ 2000; 321 doi: 10.1136/bmj.321.7274.1433/a (Published 9 December 2000)
Cite this as: BMJ 2000;321:1433.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Deborah Josefson
  1. New York

    Researchers have successfully vaccinated macque monkeys against the Ebola virus, inducing full protection against this fatal infection and inspiring hope that a human vaccine will soon follow (Nature 2000;408:605-9).

    Ebola virus mysteriously appeared in Sudan and Zaire (formerly the Congo) in 1976, causing haemorrhagic fevers and rapidly killing up to 90% of those infected. The virus has caused periodic outbreaks in Africa ever since. An epidemic currently affecting the northern Gulu district of Uganda has so far killed 140 people.

    Ebola belongs to the family of single stranded RNA viruses known as filoviruses and causes haemorrhagic fevers with high mortality. Its natural host is unknown, but a simian reservoir is suspected.

    The virus is transmitted …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular